The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis.
BACKGROUND:Atosiban is administered to women undergoing in vitro fertilization-embryo transfer (IVF-ET) to improve pregnancy outcomes. However, the results of this treatment were controversial. We conducted this meta-analysis to investigate whether atosiban improves pregnancy outcomes in the women u...
Main Authors: | Qian-Yi Huang, Min-Hua Rong, Ai-Hua Lan, Xiao-Miao Lin, Xing-Gu Lin, Rong-Quan He, Gang Chen, Mu-Jun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5396917?pdf=render |
Similar Items
-
A prospective case–control trial to evaluate and compare the efficacy and safety of atosiban versus placebo in In vitro Fertilization-embryo transfer program
by: Vineet Mishra, et al.
Published: (2018-01-01) -
Using atosiban in uterine contractions of early pregnancies after assisted reproduction
by: Ming-Yih Wu, et al.
Published: (2011-12-01) -
Management of preterm labor: atosiban or nifedipine?
by: Roel de Heus, et al.
Published: (2010-05-01) -
COMPAREMENT OF LOCALIZA ATOSIBAN AND HEXOPRENALINE IN PREMATURE DELIVERY BEFORE 32 AND AFTER 32 WEEKS OF PREGNANCY
by: O. R. Baev, et al.
Published: (2017-10-01) -
Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth
by: Mariusz Grzesiak, et al.
Published: (2018-01-01)